Pfizer Inc. (NYSE:PFE)

The financial ratios presented demonstrate notable shifts over the five-year period. Generally, reported ratios exhibit similar trends to their adjusted counterparts, though the magnitude of change often differs. A significant decline in profitability and asset utilization is apparent, particularly when considering the adjusted figures.

Asset Turnover

Both the reported and adjusted total asset turnover ratios decreased substantially from 2021 to 2023, falling from 0.45 and 0.46 respectively, to 0.26 and 0.26. These ratios remained relatively stable between 2023 and 2025, hovering around 0.30 and 0.31. This suggests a decreasing efficiency in utilizing assets to generate revenue, with a stabilization in recent periods.

Liquidity

The reported and adjusted current ratios experienced a decline from 2021 to 2023, moving from 1.40 and 1.44 to 0.91 and 0.94. A partial recovery is observed in 2024 and 2025, with both ratios stabilizing around 1.17 and 1.23 respectively. This indicates a weakening, then stabilization, of the company’s short-term liquidity position.

Leverage

Reported debt to equity increased from 0.50 in 2021 to 0.81 in 2023, before decreasing slightly to 0.73 and 0.75 in 2024 and 2025. The adjusted debt to equity ratio follows a similar pattern, increasing from 0.53 to 0.83, then decreasing to 0.77 and 0.80. The debt to capital ratio shows a comparable trend, rising from 0.33 to 0.45 and then stabilizing. Financial leverage also increased from 2.35 to 2.54 between 2021 and 2023, before decreasing slightly to 2.42 and 2.41. These trends suggest an increasing reliance on debt financing, followed by a period of stabilization.

Profitability

Reported net profit margin peaked at 31.01% in 2022 before experiencing a dramatic decline to 3.56% in 2023, with a partial recovery to 12.62% and 12.42% in 2024 and 2025. The adjusted net profit margin demonstrates an even more pronounced shift, falling to -0.25% in 2023 before recovering to 9.69% and 8.28%. This indicates a substantial decrease in profitability in 2023, followed by a recovery, though the adjusted figures suggest a more significant initial impact. Similar trends are observed in both reported and adjusted return on equity (ROE) and return on assets (ROA), with significant declines in 2023 and subsequent partial recoveries. Notably, the adjusted ROE and ROA are negative in 2023.

The adjustments to these ratios consistently demonstrate a more pronounced impact from underlying accounting changes, particularly regarding profitability metrics. The divergence between reported and adjusted figures suggests that certain accounting treatments significantly influence the perceived financial performance of the company.

The period under review demonstrates fluctuating performance in revenue generation relative to asset utilization. Revenues experienced a substantial increase between 2021 and 2022, followed by a significant decline in 2023, with modest recovery in subsequent years. Total assets generally increased through 2023 before decreasing in 2024 and 2025. Analysis of the adjusted total asset turnover ratio reveals a similar pattern, offering insights into the efficiency with which assets are employed to generate sales.

Adjusted Total Asset Turnover

The adjusted total asset turnover ratio exhibited an initial increase from 0.46 in 2021 to 0.52 in 2022, mirroring the revenue growth during that period. This indicates improved efficiency in asset utilization. However, the ratio then decreased sharply to 0.26 in 2023, coinciding with the substantial revenue decline. While the ratio experienced a slight recovery to 0.31 in both 2024 and 2025, it remained considerably lower than the 2022 peak. This suggests that despite revenue stabilization, the company has not fully regained its prior asset utilization efficiency.

The close correlation between revenue trends and the adjusted total asset turnover ratio suggests a strong relationship between sales performance and asset efficiency. The decrease in both metrics in 2023 warrants further investigation to determine the underlying causes, such as changes in operational efficiency, asset composition, or market conditions. The stabilization of the ratio in 2024 and 2025, while positive, indicates a need for continued focus on improving asset utilization to drive future revenue growth.

Revenue Trend

Revenues increased from US$82,145 million in 2021 to US$101,175 million in 2022, representing a significant expansion in sales. This was followed by a substantial decrease to US$59,553 million in 2023. Revenues showed a modest recovery in 2024, reaching US$63,627 million, and remained relatively stable at US$62,579 million in 2025. The volatility in revenue suggests potential sensitivity to external factors or internal strategic shifts.

Asset Trend

Total assets increased from US$181,476 million in 2021 to US$197,205 million in 2022 and continued to rise to US$226,501 million in 2023. A decrease was then observed in 2024, with total assets falling to US$213,396 million, and this downward trend continued in 2025, reaching US$208,160 million. The asset growth preceding 2024 may have been intended to support the revenue expansion, but the subsequent decline suggests potential asset optimization or divestment activities.

The adjusted current ratio exhibited fluctuations over the five-year period. Initially, the ratio demonstrated a slight decline followed by a period of relative stability. A review of the underlying components reveals trends in both adjusted current assets and adjusted current liabilities that contribute to these observed changes.

Adjusted Current Ratio Trend

The adjusted current ratio began at 1.44 in 2021, decreased to 1.26 in 2022, and then further declined to 0.94 in 2023. A subsequent increase to 1.23 was noted in 2024, followed by a slight decrease to 1.22 in 2025. This indicates a period of weakening short-term liquidity, a partial recovery, and then stabilization.

Adjusted Current Assets

Adjusted current assets showed an initial increase from 60,185 in 2021 to 60,708 in 2022, before decreasing to 43,803 by 2023. A recovery to 50,796 was observed in 2024, but this was followed by a slight decrease to 43,325 in 2025. The largest decrease occurred between 2022 and 2023.

Adjusted Current Liabilities

Adjusted current liabilities decreased from 41,855 in 2021 to 41,147 in 2022. However, they then increased to 46,469 in 2023. A decrease to 41,312 was seen in 2024, followed by a further decrease to 35,540 in 2025. The increase in 2023 contributed to the lowest adjusted current ratio during the period.

Relationship between Assets and Liabilities

The decline in the adjusted current ratio in 2022 and 2023 was primarily driven by a combination of decreasing adjusted current assets and increasing adjusted current liabilities. The subsequent improvement in 2024 was due to a larger increase in adjusted current assets than the increase in adjusted current liabilities. The stabilization in 2025 reflects a continued decrease in adjusted current liabilities, partially offset by a decrease in adjusted current assets.

Overall, the adjusted current ratio suggests a fluctuating short-term liquidity position. While the ratio recovered somewhat in the later years, the initial decline and subsequent volatility warrant continued monitoring.

The adjusted debt to equity ratio exhibits an increasing trend over the five-year period. Total debt experienced a notable increase between 2021 and 2023, before decreasing slightly in 2024 and 2025. Shareholders’ equity generally decreased from 2022 through 2025, contributing to the observed ratio trend. The adjusted figures differ from the reported figures, suggesting adjustments are being made to the components of debt and equity.

Adjusted Debt to Equity Ratio Trend

The adjusted debt to equity ratio increased from 0.53 in 2021 to 0.83 in 2023, representing a substantial rise in leverage. While the ratio decreased slightly to 0.77 in 2024 and remained at 0.80 in 2025, it remained significantly higher than the 2021 level. This indicates a growing reliance on debt financing relative to equity.

Total Debt Analysis

Total debt increased significantly from US$35,829 million in 2022 to US$71,888 million in 2023. This represents the largest single-year increase in total debt over the observed period. Subsequent years show a decrease, with debt settling at US$64,795 million in 2025. The adjusted total debt figures follow a similar pattern, consistently higher than the reported total debt.

Shareholders’ Equity Analysis

Total shareholders’ equity peaked at US$95,661 million in 2022 before experiencing a consistent decline through 2025, reaching US$86,476 million. The adjusted total equity mirrors this trend, though the absolute values differ. The decrease in equity, combined with the fluctuations in debt, directly impacts the debt to equity ratio.

Comparison of Reported and Adjusted Ratios

The adjusted debt to equity ratio is consistently higher than the reported debt to equity ratio across all observed years. This suggests that the adjustments made to total debt and total equity result in a higher leverage profile when considered in their adjusted form. The magnitude of the difference between the reported and adjusted ratios remains relatively stable over time.

Overall, the financial position appears to be becoming more leveraged, as indicated by the increasing adjusted debt to equity ratio. The substantial increase in debt in 2023, coupled with the subsequent decline in shareholders’ equity, are key drivers of this trend.

The information presents a five-year trend of debt and capital figures, culminating in adjusted debt-to-capital ratios. Total debt exhibited a decrease from 2021 to 2022, followed by a substantial increase in 2023, before declining modestly in 2024 and remaining relatively stable in 2025. Total capital generally increased from 2021 to 2023, then experienced a slight decrease in 2024 and a further, minimal decrease in 2025.

Reported Debt to Capital

The reported debt-to-capital ratio decreased from 0.33 in 2021 to 0.27 in 2022. This was followed by an increase to 0.45 in 2023, and a subsequent decrease to 0.42 in 2024. The ratio remained at 0.43 in 2025, indicating a stabilization after the 2023 increase. The fluctuations largely mirror the changes observed in total debt.

Adjusted Total Debt

Adjusted total debt followed a similar pattern to total debt, decreasing from 2021 to 2022, increasing significantly in 2023, and then decreasing slightly in 2024 and 2025. The magnitude of the increase in 2023 was notably larger for adjusted total debt compared to total debt, suggesting the adjustments added a substantial amount to the debt figure in that year.

Adjusted Total Capital

Adjusted total capital demonstrated a consistent upward trend from 2021 to 2023, increasing from 119,151 to 165,659. Similar to total capital, adjusted total capital experienced a slight decline in both 2024 and 2025, though remaining significantly above the 2021 level.

Adjusted Debt to Capital

The adjusted debt-to-capital ratio decreased from 0.35 in 2021 to 0.29 in 2022, mirroring the trend in adjusted total debt. The ratio then increased to 0.45 in 2023, and remained stable at 0.44 in 2024 and 0.45 in 2025. The stabilization in 2024 and 2025 suggests that the increases in both adjusted debt and adjusted capital are occurring at a similar rate during those periods. The adjusted ratio consistently remains slightly higher than the reported ratio across all years.

Overall, the period demonstrates a dynamic relationship between debt and capital. The significant increase in both total and adjusted debt in 2023 warrants further investigation to understand the underlying drivers. The subsequent stabilization of the adjusted debt-to-capital ratio in 2024 and 2025 suggests a potential balancing of debt and capital structures.

An examination of the financial information reveals trends in adjusted financial leverage over a five-year period. Total assets exhibited an increasing trajectory from 2021 to 2023, peaking at US$226.501 billion, before declining in both 2024 and 2025 to US$208.160 billion. Total shareholders’ equity followed a similar pattern, increasing from US$77.201 billion in 2021 to US$95.661 billion in 2022, then decreasing to US$86.476 billion by 2025. The adjusted figures for total assets and equity mirrored these trends, though with slight variations in magnitude.

Reported Financial Leverage

Reported financial leverage initially decreased from 2.35 in 2021 to 2.06 in 2022, indicating a reduced reliance on debt financing relative to equity. However, it subsequently increased to 2.54 in 2023 before stabilizing at approximately 2.42 in 2024 and 2.41 in 2025. This suggests a renewed, albeit moderate, increase in financial risk during the latter part of the period.

Adjusted Financial Leverage

Adjusted financial leverage demonstrated a similar pattern to the reported leverage. It decreased from 2.32 in 2021 to 2.06 in 2022, then rose to 2.49 in 2023. The adjusted leverage ratio then remained relatively stable at 2.39 in both 2024 and 2025. The consistency between reported and adjusted leverage suggests that adjustments to assets and equity did not significantly alter the overall assessment of the company’s financial risk profile.

The convergence of the reported and adjusted leverage ratios indicates that the adjustments made to total assets and equity did not materially impact the overall leverage position. The slight increase in leverage observed from 2022 to 2023, followed by stabilization, warrants continued monitoring to assess the sustainability of the company’s capital structure.

The financial performance, as indicated by net income and revenues, experienced significant fluctuations between 2021 and 2025. While revenues increased from 2021 to 2022, they subsequently declined, stabilizing in the latter years of the observed period. Net income attributable to Pfizer Inc. common shareholders mirrored this pattern, peaking in 2022 before experiencing a substantial decrease and subsequent modest recovery.

Reported Net Profit Margin

The reported net profit margin demonstrated a peak of 31.01% in 2022, following a value of 26.76% in 2021. A considerable decline was observed in 2023, falling to 3.56%, before partially recovering to 12.62% and 12.42% in 2024 and 2025, respectively. This suggests a significant impact on profitability in 2023, followed by some stabilization in the subsequent two years.

Adjusted Net Profit Margin

The adjusted net profit margin generally followed the trend of the reported net profit margin, though with differing magnitudes. It reached 25.00% in 2022, decreasing to -0.25% in 2023, indicating a net loss when adjustments are considered. The adjusted margin then rose to 9.69% in 2024 and 8.28% in 2025. The negative value in 2023 highlights the impact of adjustments on the company’s profitability during that year, suggesting that certain items significantly affected the underlying earnings.

The divergence between the reported and adjusted net profit margins indicates the presence of items requiring adjustment to provide a clearer picture of ongoing operational performance. The substantial decline in both margins in 2023, particularly the adjusted margin turning negative, warrants further investigation into the nature of these adjustments and their underlying causes. The stabilization of both margins in 2024 and 2025 suggests a potential leveling off of these impacts, but continued monitoring is advisable.

Revenue and Profitability Relationship

The decrease in revenues from 2022 to 2023 coincided with a dramatic drop in both reported and adjusted net profit margins. While revenues stabilized between 2023 and 2025, the profitability metrics did not fully recover to 2021/2022 levels, suggesting that factors beyond revenue volume are influencing profitability. This could include changes in cost of goods sold, operating expenses, or the impact of the aforementioned adjustments.

The reported return on equity (ROE) exhibited a substantial increase from 2021 to 2022, peaking at 32.79%, before declining significantly in subsequent years. By 2023, the reported ROE decreased to 2.38%, and while it recovered somewhat in 2024 and 2025, it remained relatively low at 9.11% and 8.99% respectively. A similar pattern is observed in the adjusted ROE, though the magnitudes of change differ.

Adjusted Return on Equity (ROE) Trend

The adjusted ROE followed a similar trajectory to the reported ROE, increasing from 22.93% in 2021 to 26.96% in 2022. However, it experienced a more dramatic decline in 2023, resulting in a negative value of -0.16%. The adjusted ROE showed a recovery in 2024 and 2025, reaching 7.12% and 6.16% respectively, but remained below the levels observed in 2021 and 2022.

Net income attributable to Pfizer Inc. common shareholders demonstrated a strong increase between 2021 and 2022, rising from US$21,979 million to US$31,372 million. This was followed by a substantial decrease in 2023 to US$2,119 million, with a partial recovery to US$8,031 million in 2024 and US$7,771 million in 2025. The adjusted net income before allocation to noncontrolling interests mirrored this trend, with a significant decline into negative territory in 2023 (-US$149 million) before recovering in 2024 and 2025.

Equity Changes

Total Pfizer Inc. shareholders’ equity increased from US$77,201 million in 2021 to US$95,661 million in 2022. Subsequently, equity decreased to US$89,014 million in 2023, and continued a slight downward trend to US$88,203 million in 2024 and US$86,476 million in 2025. Adjusted total equity exhibited a similar pattern, though the absolute values differ.

The divergence between reported and adjusted ROE suggests the presence of items impacting net income that are being excluded in the adjusted calculation. The negative adjusted ROE in 2023, coupled with the significantly reduced adjusted net income, indicates a substantial impact from these adjustments in that year. The subsequent recovery in both adjusted net income and adjusted ROE in 2024 and 2025 suggests a lessening of this impact, but the levels remain below those observed in the earlier period.

The adjusted return on assets (ROA) exhibited fluctuating performance over the five-year period. Initially, the adjusted ROA demonstrated growth, followed by a significant decline and subsequent stabilization at a lower level. A detailed examination of the underlying components reveals key trends.

Adjusted ROA Trend

The adjusted ROA began at 9.89% in 2021, increasing to 13.11% in 2022. A substantial decrease was then observed in 2023, resulting in a negative adjusted ROA of -0.07%. This negative value indicates a net loss relative to adjusted assets. The adjusted ROA partially recovered in 2024 to 2.97%, and remained relatively stable in 2025 at 2.58%.

Net Income Impact

Adjusted net income before allocation to noncontrolling interests generally followed a similar pattern to the adjusted ROA. It increased from US$17,829 million in 2021 to US$25,290 million in 2022. However, it experienced a dramatic decline in 2023, posting a loss of US$149 million. Subsequent years showed positive, but lower, adjusted net income of US$6,163 million in 2024 and US$5,182 million in 2025. This suggests that changes in net income were a primary driver of the fluctuations in adjusted ROA.

Asset Base

Adjusted total assets increased steadily from US$180,350 million in 2021 to US$225,203 million in 2023. A decrease was then observed in 2024, falling to US$207,261 million, and continued to decline slightly in 2025 to US$201,153 million. The asset growth in the earlier years did not translate into proportional increases in adjusted net income, and the subsequent asset reduction did not fully offset the impact of lower net income in 2023 and 2024.

Comparison to Reported ROA

The adjusted ROA consistently fell below the reported ROA across all observed years. The difference between the two metrics suggests that adjustments made to net income and total assets had a dampening effect on the overall return calculation. The largest divergence occurred in 2023, where the reported ROA was 0.94% while the adjusted ROA was -0.07%.

In summary, the adjusted ROA experienced a period of growth followed by a significant downturn and subsequent stabilization at a lower level. This performance was closely tied to fluctuations in adjusted net income, while the asset base exhibited a different trend, initially increasing and then decreasing. The adjustments made to net income and total assets resulted in a consistently lower adjusted ROA compared to the reported ROA.